Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activator protein 1 (AP-1) is a transcription factor complex that regulates gene expression in response to a wide range of stimuli. It is a dimeric complex formed by members of the Jun, Fos, ATF, Maf, and JDP protein families. AP-1 plays critical roles in cellular processes such as differentiation, proliferation, apoptosis, and oncogenic transformation. Activated AP-1 binds to specific DNA sequences (TREs and CREs) in promoter regions of target genes. Dysregulation of AP-1 has been implicated in cancer development/progression due to its role in cell cycle control and apoptosis resistance.
Modulation of AP-1 activity often involves targeting upstream kinases in the MAPK and PI3K/Akt pathways, or direct inhibition of AP-1 dimerization or DNA binding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activator Protein 1 (None).